Home/Pipeline/Coronary Sinus Reduction

Coronary Sinus Reduction

Heart Failure

UnknownActive

Key Facts

Indication

Heart Failure

Phase

Unknown

Status

Active

Company

Shockwave Medical

About Shockwave Medical

Shockwave Medical is a commercial-stage medical device innovator that has developed a novel Intravascular Lithotripsy (IVL) system for disrupting vascular calcium. Founded in 2009 and now part of Johnson & Johnson MedTech, the company's technology addresses a significant unmet need in interventional cardiology and vascular medicine, offering a safer and more predictable alternative to existing treatments for calcified lesions. With established products in coronary and peripheral markets and a clear reimbursement pathway, Shockwave is positioned for continued growth in a large and expanding global market.

View full company profile

Therapeutic Areas

Cardiovascular

Other Heart Failure Drugs

Drug	Company	Phase	Status
Cardiac Cell Therapy Program	StemCardia	Pre-clinical	Active
NTP42	ATXA Therapeutics	Preclinical	Platform potential identified
Heart Failure Trial	Clinical Investigation Specialists	Not Specified	Actively Recruiting
INPEFA (sotagliflozin)	Lexicon Pharmaceuticals	Approved	Commercial
MyCardia™	Avery Therapeutics	Pre-clinical	Active
Cardiac Assist Device	Second Heart Assist	Pre-clinical	Active
Isosorbide Dinitrate/Hydralazine HCl Tablets	i3 Pharmaceuticals	Approved	Active
TLT-101	TikkunLev Therapeutics	Pre-clinical	Active
Undisclosed Heart Regeneration Program	Animatus Biosciences	Pre-clinical	Active
AFteR Registry	Occlutech	N/A (Registry)	Active
biotx.ai Target Discovery Collaboration	HeartBeat.bio	Pre-clinical	Active
Surlorian	RyCarma Therapeutics	Phase 2	Active